1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. Switzerland >
  5. Boston Scientific Acquires Symetis SA

M&A Deal Summary

Boston Scientific Acquires Symetis SA

On March 30, 2017, Boston Scientific acquired medical products company Symetis SA for 435M USD

Acquisition Highlights
  • This is Boston Scientific’s 29th transaction in the Medical Products sector.
  • This is Boston Scientific’s 14th largest (disclosed) transaction.
  • This is Boston Scientific’s 1st transaction in Switzerland.

M&A Deal Summary
Date 2017-03-30
Target Symetis SA
Sector Medical Products
Buyer(s) Boston Scientific
Deal Type Add-on Acquisition
Deal Value 435M USD

Target

Symetis SA

Lausanne, Switzerland
Symetis SA is a developer of innovative, minimally invasive heart valve replacement devices. The company’s products, ACURATE TA™ and ACURATE neo™ and their delivery systems, based on proprietary design and delivery technologies, are marketed and sold in key markets in Europe and in other markets, and are well positioned to target the constantly growing TAVI market.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Boston Scientific

Marlborough, Massachusetts, United States
Category Company
Founded 1979
Sector Medical Products
Employees48,000
Revenue 16.7B USD (2024)
DESCRIPTION
Entrance to Boston Scientific's corporate headquarters in Marlborough, Massachusetts.
Entrance to Boston Scientific's corporate headquarters in Marlborough, Massachusetts.

Boston Scientific is a medical technology company that offers products and technologies used to diagnose and treat a wide range of medical conditions, including heart, digestive, pulmonary, vascular, urological, women's health, and chronic pain conditions. Boston Scientific was founded in 1979 and is based in Marlborough, Massachusetts.

DEAL STATS #
Overall 41 of 70
Sector: Medical Products M&A 29 of 53
Type: Add-on Acquisition M&A Deals 32 of 54
Country: Switzerland M&A 1 of 1
Year: 2017 M&A 1 of 2
Size (of disclosed) 14 of 36
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-12-02 Neovasc - Biological Tissue Capabilities

Richmond, British Columbia, Canada

Neovasc, Inc. - Biological Tissue Capabilities is a manufacturer of medical products in Canada.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2017-10-02 Apama Medical

Campbell, California, United States

Apama Medical, Inc. is a developer of apama radiofrequency (RF) balloon catheter system for the treatment of atrial fibrillation (AF). Apama Medical is based in Campbell, California.

Buy $175M
Mergr

Solution for

Product

Company

Legal